NFE2L2 and acute lymphoblastic leukemia: However, increasing efforts are needed in order to better characterize the genetic or epigenetic mechanisms underlying NRF2/AKR1C1-3 de-regulation in T-ALL before they could be exploited as reliable prognostic tools.